Rocket Pharmaceuticals (RCKT) Cash & Current Investments (2014 - 2026)
Rocket Pharmaceuticals (RCKT) recorded Cash & Current Investments of $283.7 million in Q2 2026, up 4.5% from $271.5 million a year earlier and up 96.5% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals reported Cash & Current Investments of $188.9 million, down 49.3% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -17.1% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $372.3 million in FY2024 (-8.6%), $407.5 million in FY2023 (+14.3%), $356.39 million in FY2022 (-8.3%) and $388.7 million in FY2021 (-19.5%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q1 2025.
- On a year-over-year basis, Cash & Current Investments rose in 1 of the last eight quarters, with an average decline of 20.7%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 84.3% in Q3 2021, against a decline of 54.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $144.4 million (Q1 2026), $188.9 million (Q4 2025) and $222.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Rocket Pharmaceuticals | 250.85 Mn | -32.85 Mn | - | 283.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 283.70 Mn |
| Mar 31, 2026 | 144.40 Mn |
| Dec 31, 2025 | 188.90 Mn |
| Sep 30, 2025 | 222.80 Mn |
| Jun 30, 2025 | 271.50 Mn |
| Mar 31, 2025 | 318.20 Mn |
| Dec 31, 2024 | 372.30 Mn |
| Sep 30, 2024 | 235.70 Mn |
| Jun 30, 2024 | 278.80 Mn |
| Mar 31, 2024 | 330.30 Mn |
| Dec 31, 2023 | 407.50 Mn |
| Sep 30, 2023 | 437.20 Mn |
| Jun 30, 2023 | 307.00 Mn |
| Mar 31, 2023 | 360.00 Mn |
| Dec 31, 2022 | 356.39 Mn |
| Sep 30, 2022 | 306.50 Mn |
| Jun 30, 2022 | 321.40 Mn |
| Mar 31, 2022 | 346.60 Mn |
| Dec 31, 2021 | 388.70 Mn |
| Sep 30, 2021 | 421.50 Mn |
API Access
Rocket Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();